A novel method for detecting SARS-CoV-2 seroprevalence
In a preprint, not yet peer-reviewed, CITF-funded researchers developed a novel approach to detect SARS-CoV-2 anti-nucleocapsid antibodies. The ratio-based approach had a 95.2% sensitivity among both previously vaccinated and previously infected donors compared with 63.3% for the conventional approach.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed